Evli Nordic B vs UBS Lux Equity Fund Biotech USD

Evli Nordic B vs UBS Lux Equity Fund Biotech USD

1. Evli Nordic B

  • Security

    Evli Nordic B

  • Fee

    1.61%

  • ISIN

    FI0008810908

  • Holdings

    23

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

Fund Holdings

We have information about 22 holdings in Evli Nordic B, where the largest holding is Orkla (4.95), followed by Betsson (4.9) and Loomis (4.48). In comparison with UBS Lux Equity Fund Biotech USD, we have 11 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Vertex (8.44).

All Holdings

Here we compare the holdings in Evli Nordic B and UBS Lux Equity Fund Biotech USD.

Evli Nordic B UBS Lux Equity Fund Biotech USD
1. Orkla Foods AS
Norway
4.95 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Betsson B
4.9 %
2. Moderna Inc
9.21 %
3. Loomis B
Sweden
4.48 %
3. Vertex Pharmaceuticals Inc
8.44 %
4. Wärtsilä Oyj Abp
3.46 %
4. Alnylam Pharmaceuticals Inc
8.08 %
5. Kemira Oyj
3.44 %
5. AbbVie Inc
USA
4.91 %
6. Konecranes Oyj
Finland
3.34 %
6. Gilead Sciences Inc
USA
4.66 %
7. Atea
3.18 %
7. Amgen Inc
USA
4.43 %
8. Assa Abloy B
Sweden
3.12 %
8. BioNTech SE
4.13 %
9.
3.08 %
9. Karuna Therapeutics Inc
3.75 %
10. Wallenius Wilhelmsen ASA
Norway
2.9 %
-
11. Aker Solutions ASA
Norway
2.81 %
-
12. Pandora A/S
Denmark
2.79 %
-
13. Equinor ASA
Norway
2.76 %
-
14. Carlsberg B
2.74 %
-
15. Elisa Oyj
Finland
2.47 %
-
16. Crayon Group Holding ASA
Norway
2.46 %
-
17. ISS A/S
Denmark
2.45 %
-
18. DSV Panalpina
Denmark
2.42 %
-
19. Ericsson B
Sweden
2.39 %
-
20. Evolution Gaming Group AB
Sweden
2.3 %
-
21. Demant A/S
Denmark
2.26 %
-
22. Hexpol B
Sweden
2.21 %
-
23. Valmet Oyj
2.12 %
-

The list of fund holdings was last updated on July 27, 2025.